Understanding Liver Steatosis: The Warning Sign in MASLD
Liver steatosis commonly known as fatty liver is no longer a silent bystander in liver health. It’s the central feature […]
Liver steatosis commonly known as fatty liver is no longer a silent bystander in liver health. It’s the central feature […]
When people think about liver disease, the conversation usually centers around fibrosis – the amount of permanent scarring in the
Explore the essentials of LIVERFASt® with this simplified brochure. Learn how this innovative, blood-based diagnostic tool stages fibrosis, activity, and
MASLD affects more than 25% of subjects of the general population and can progress to advanced fibrosis (AF) and cirrhosis
Hepatitis C virus (HCV) infection is a common cause of both liver cirrhosis and hepatocellular carcinoma. Successful Direct antiviral agents
AI-based blood tests LIVERSTAT for advanced fibrosis (AF) in patients with T2D can streamline the diagnostic process. Aim of this
The study aims to compare retrospectively two combinations for one-step assessment of advanced fibrosis: LIVERFASt Fibrosis & Liver Stiffness Measurement
Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are conditions tied to the buildup of fat in
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where fat accumulates in the liver, mainly due to issues with
Did you know that metabolic health plays a key role in liver function? With the rise in conditions like obesity,